Beijing Tiantan Biological Products Corporation Limited Class ASSE: 600161

Announcement on Termination of Drug Clinical Trial of Subsidiary

· Issued by Beijing Tiantan Biological Products Corporation Limited Class A via Shanghai Stock Exchange
Announcement on Termination of Drug Clinical Trial of Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment